Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Letvin: rAdenoviral & rMycobacterial Vector Immunogens |
| Strategy: | Combo: Protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2012-05-01 |
| Study Made Public: | 2015-06-19 |
Title
Microarray signatures of the RV144 prime/boost regimen in non-human primates
Description
CAVD 364 is a non-human primate study of ALVAC-HIV (vCP1521) and AIDSVAX B/E prime/boost regimens.
Sign in to see full information about this study and to download study data.
Products
ALVAC (vCP1521) AIDSVAX B/E Placebo ALVACIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.